ZIM LABORATORIES Financial Statement Analysis
|
||
The Revenues of ZIM LABORATORIES have increased by 3.16% YoY .
The Earnings Per Share (EPS) of ZIM LABORATORIES has decreased by -29.38 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
ZIM LABORATORIES Last 5 Annual Financial Results
[BOM: 541400|NSE : ZIMLAB]
Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
---|---|---|---|---|---|
Revenues | ₹379 Cr | ₹367 Cr | ₹399 Cr | ₹333 Cr | ₹307 Cr |
Expenses | ₹335 Cr | ₹326 Cr | ₹347 Cr | ₹292 Cr | ₹268 Cr |
Operating Profit (Excl OI) | ₹44 Cr | ₹41 Cr | ₹52 Cr | ₹41 Cr | ₹40 Cr |
Other Income | ₹5.78 Cr | ₹5.18 Cr | ₹6.41 Cr | ₹4.40 Cr | ₹2.34 Cr |
Interest | ₹11 Cr | ₹6.92 Cr | ₹5.58 Cr | ₹8.31 Cr | ₹11 Cr |
Depreciation | ₹20 Cr | ₹16 Cr | ₹17 Cr | ₹16 Cr | ₹16 Cr |
Profit Before Tax | ₹18 Cr | ₹24 Cr | ₹35 Cr | ₹21 Cr | ₹10 Cr |
Profit After Tax | ₹12 Cr | ₹17 Cr | ₹24 Cr | ₹15 Cr | ₹7.32 Cr |
Consolidated Net Profit | ₹12 Cr | ₹17 Cr | ₹24 Cr | ₹15 Cr | ₹7.32 Cr |
Earnings Per Share (Rs) | ₹2.50 | ₹3.54 | ₹5.01 | ₹8.96 | ₹4.51 |
PAT Margin (%) | 3.21 | 4.69 | 6.13 | 4.36 | 2.38 |
ROE(%) | 4.97 | 7.86 | 13.00 | 8.65 | 4.66 |
ROCE(%) | 8.29 | 10.11 | 16.82 | 12.52 | 8.70 |
Total Debt/Equity(x) | 0.45 | 0.44 | 0.30 | 0.29 | 0.50 |
Key Financials |
||
Market Cap | : | ₹ 512.3 Cr |
Revenue (TTM) | : | ₹ 379.0 Cr |
Net Profit(TTM) | : | ₹ 12.2 Cr |
EPS (TTM) | : | ₹ 2.5 |
P/E (TTM) | : | 42.1 |
Industry Peers & Returns | 1W | 1M | 1Y |
ZIM LABORATORIES | 1.3% | 18.9% | 3.5% |
SUN PHARMACEUTICAL INDUSTRIES | -2.5% | -4.9% | 8.7% |
DIVIS LABORATORIES | -2.7% | -0.9% | 42.5% |
CIPLA | -1.5% | 0.1% | -4.3% |
TORRENT PHARMACEUTICALS | -2.6% | -3.7% | 11.9% |
DR REDDYS LABORATORIES | -2.6% | 8.3% | 7.9% |
MANKIND PHARMA | -2.5% | -8.3% | 5.2% |
ZYDUS LIFESCIENCES | -2.6% | 6.8% | -13.6% |
LUPIN | -3.4% | -3.2% | 21.8% |
ZIM LABORATORIES Revenues
[BOM: 541400|NSE : ZIMLAB]
Y-o-Y | 3.16 % |
5 Yr CAGR | 5.39 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹379 Cr | 3.16 | |
Mar2024 | ₹367 Cr | -7.80 | |
Mar2023 | ₹399 Cr | 19.52 | |
Mar2022 | ₹333 Cr | 8.52 | |
Mar2021 | ₹307 Cr | - |
ZIM LABORATORIES Operating Profit
[BOM: 541400|NSE : ZIMLAB]
Y-o-Y | 5.79 % |
5 Yr CAGR | 2.40 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹44 Cr | 5.79 | |
Mar2024 | ₹41 Cr | -20.49 | |
Mar2023 | ₹52 Cr | 26.86 | |
Mar2022 | ₹41 Cr | 3.06 | |
Mar2021 | ₹40 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 2.58 % |
5 Yr CAGR | -2.82 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 11.54% | 2.58 | |
Mar2024 | 11.25% | -13.73 | |
Mar2023 | 13.04% | 6.10 | |
Mar2022 | 12.29% | -5.02 | |
Mar2021 | 12.94% | - |
ZIM LABORATORIES Profit After Tax
[BOM: 541400|NSE : ZIMLAB]
Y-o-Y | -29.46 % |
5 Yr CAGR | 13.55 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹12 Cr | -29.46 | |
Mar2024 | ₹17 Cr | -29.42 | |
Mar2023 | ₹24 Cr | 67.94 | |
Mar2022 | ₹15 Cr | 98.82 | |
Mar2021 | ₹7.32 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -31.56 % |
5 Yr CAGR | 7.77 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 3.21 % | -31.56 | |
Mar2024 | 4.69 % | -23.49 | |
Mar2023 | 6.13 % | 40.60 | |
Mar2022 | 4.36 % | 83.19 | |
Mar2021 | 2.38 % | - |
ZIM LABORATORIES Earnings Per Share (EPS)
[BOM: 541400|NSE : ZIMLAB]
Y-o-Y | -29.38 % |
5 Yr CAGR | -13.71 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹2.50 | -29.38 | |
Mar2024 | ₹3.54 | -29.34 | |
Mar2023 | ₹5.01 | -44.08 | |
Mar2022 | ₹8.96 | 98.67 | |
Mar2021 | ₹4.51 | - |
ZIM LABORATORIES Return on Capital Employed (ROCE)
[BOM: 541400|NSE : ZIMLAB]
Y-o-Y | -18.00 % |
5 Yr CAGR | -1.20 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2025 | 8.29% | -18.00 | |
Mar2024 | 10.11% | -39.89 | |
Mar2023 | 16.82% | 34.35 | |
Mar2022 | 12.52% | 43.91 | |
Mar2021 | 8.7% | - |
ZIM LABORATORIES Share Price vs Sensex
Current Share Price | : | ₹105.2 |
Current MarketCap | : | ₹ 512.3 Cr |
Updated EOD on | : | Jun 19,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZIM LABORATORIES | 1.3% |
18.9% |
3.5% |
SENSEX | -0.4% |
0.2% |
5.9% |
ZIM LABORATORIES related INDICES
You may also like the below Video Courses
FAQ about ZIM LABORATORIES Financials
How the annual revenues of ZIM LABORATORIES have changed ?
The Revenues of ZIM LABORATORIES have increased by 3.16% YoY .
How the Earnings per Share (EPS) of ZIM LABORATORIES have changed?
The Earnings Per Share (EPS) of ZIM LABORATORIES has decreased by -29.38 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs